BioAge CEO to Lead a Panel Discussion at the BIO 2022 Conference: 'Targeting Aging Pathways to Treat Chronic Disease' — June 14, 2022, 11 AM
businesswire.com
news
2022-05-31 00:00:00

May 31, 2022 06:00 AM Eastern Daylight Time RICHMOND, Calif.--(BUSINESS WIRE)--BioAge Labs, Inc. ('BioAge', 'the Company'), a biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced that Kristen Fortney, PhD, CEO and Co-Founder of BioAge, will lead a panel discussion at the BIO International Conference held June 13–16, 2022 in San Diego, California ('BIO 2022').



Event details are as follows:



Title:



Targetin
